Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
Alzheimer’s disease: an innovative non-drug trial gets underway in Toulouse
A promising new treatment for concussion and Alzheimer’s victims?

The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis

11th Clinical Trials on Alzheimer’s Disease (CTAD) 2018, Barcelona

Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Guillaume J. Blivet, Jacques Touchon.

Share this article